Screener
Fulgent Genetics, Inc. FLGT Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total assets | $1,156,369 | $1,213,525 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities | ||
| Accounts payable | $21,125 | $18,654 |
| Accrued liabilities | 34,901 | 34,057 |
| Customer deposit | 30,619 | 28,145 |
| Contract liabilities | 3,007 | 3,635 |
| Notes payable, current | 482 | 476 |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s accounts payable?
- Fulgent Genetics, Inc. (FLGT) reported accounts payable of $21.13M in Q1 2026.
- How has Fulgent Genetics, Inc.'s accounts payable changed year-over-year?
- Fulgent Genetics, Inc.'s accounts payable increased by 15.8% year-over-year, from $18.24M to $21.13M.
- What is the long-term trend for Fulgent Genetics, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s accounts payable has grown at a -6.8% compound annual growth rate (CAGR), from $26.49M to $18.65M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Fulgent Genetics, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude